Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Postoperative Nausea and Vomiting × Olanzapine × 90 days × Clear all

Sponsor

Conditions

Anorexia 2 Weight Loss 1 Vomiting 1 Squamous Cell Carcinoma of Head and Neck 1 Opioid-Related Disorders 1 Neoplasms 1 Nausea 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cachexia 1

Interventions

Sufentanil 1 ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡